RNA sequencing suggests that non-coding RNAs play a role in the development of acquired haemophilia

J Cell Mol Med. 2023 Jul;27(13):1790-1796. doi: 10.1111/jcmm.17741. Epub 2023 Jun 14.

Abstract

Acquired haemophilia (AH) is a rare disorder characterized by bleeding in patients with no personal or family history of coagulation/clotting-related diseases. This disease occurs when the immune system, by mistake, generates autoantibodies that target FVIII, causing bleeding. Small RNAs from plasma collected from AH patients (n = 2), mild classical haemophilia (n = 3), severe classical haemophilia (n = 3) and healthy donors (n = 2), for sequencing by Illumina, NextSeq500. Based on bioinformatic analysis, AH patients were compared to all experimental groups and a significant number of altered transcripts were identified with one transcript being modified compared to all groups at fold change level. The Venn diagram shows that haemoglobin subunit alpha 1 was highlighted to be the common upregulated transcript in AH compared to classical haemophilia and healthy patients. Non-coding RNAs might play a role in AH pathogenesis; however, due to the rarity of HA, the current study needs to be translated on a larger number of AH samples and classical haemophilia samples to generate more solid data that can confirm our findings.

Keywords: RNA sequencing; acquired haemophilia; coagulation; epigenetics; factor VIII.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Factor VIII / genetics
  • Hemophilia A* / genetics
  • Hemorrhage
  • Humans
  • RNA, Untranslated
  • Sequence Analysis, RNA

Substances

  • Factor VIII
  • RNA, Untranslated